APO RESEARCH · REPORT
Therapeutic Drug Monitoring
Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects. The process of TDM is predicated on the assumption that there is a definable relationship between dose and plasma or blood drug concentration, and between concentration and therapeutic effects. TDM begins when the drug is first prescribed, and involves determining an initial dosage regimen appropriate for the clinical condition and such patient characteristics as age, weight, organ function, and concomitant drug therapy. When interpreting concentration measurements, factors that need to be considered include the sampling time in relation to drug dose, dosage history, patient response, and the desired medicinal targets. The goal of TDM is to use appropriate concentrations of difficult-to-manage medications to optimize clinical outcomes in patients in various clinical situations.
Product & engineering
Understand the product.
Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects. The process of TDM is predicated on the assumption that there is a definable relationship between dose and plasma or blood drug concentration, and between concentration and therapeutic effects. TDM begins when the drug is first prescribed, and involves determining an initial dosage regimen appropriate for the clinical condition and such patient characteristics as age, weight, organ function, and concomitant drug therapy. When interpreting concentration measurements, factors that need to be considered include the sampling time in relation to drug dose, dosage history, patient response, and the desired medicinal targets. The goal of TDM is to use appropriate concentrations of difficult-to-manage medications to optimize clinical outcomes in patients in various clinical situations.
Selected research
Industry Research
Therapeutic Drug Monitoring Industry Research Report 2026
Market perspective
Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects. The process of TDM is predicated on the assumption that there is a definable relationship between dose and plasma or blood drug concentration, and between concentration and therapeutic effects. TDM begins when the drug is first prescribed, and involves determining an initial dosage regimen appropriate for the clinical condition and such patient characteristics as age, weight, organ function, and concomitant drug therapy. When interpreting concentration measurements, factors that need to be considered include the sampling time in relation to drug dose, dosage history, patient response, and the desired medicinal targets. The goal of TDM is to use appropriate concentrations of difficult-to-manage medications to optimize clinical outcomes in patients in various clinical situations.
Roche, Danaher and Abbott are the major companies in the industry, accounting for 17.17%, 10.36% and 8.29% of the revenue respectively in 2019. By region, North America had the highest share of income, reaching 42.31 percent in 2019.
Report Scope
Read the full market overview
This report quantifies the global Therapeutic Drug Monitoring market in terms of revenue (US$ million) and, where applicable, service volume (), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Therapeutic Drug Monitoring.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Therapeutic Drug Monitoring Market by Company
Roche
Danaher
Abbott
Thermo Fisher Scientific
Siemens Healthcare
Bio-Rad Laboratories
BioMerieux
Sanquin
Becton Dickinson
Quest Diagnostics
Therapeutic Drug Monitoring Segment by Type
Blood Test
Urine Test
Saliva Test
Other Test
Therapeutic Drug Monitoring Segment by Application
Hospital Labs
Private Labs
Others
Therapeutic Drug Monitoring Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Drug Monitoring market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Therapeutic Drug Monitoring and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Drug Monitoring.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Therapeutic Drug Monitoring companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Blood Test
- Urine Test
- Saliva Test
- Other Test
Applications
- Hospital Labs
- Private Labs
- Others
Companies covered
- Roche
- Danaher
- Abbott
- Thermo Fisher Scientific
- Siemens Healthcare
- Bio-Rad Laboratories
- BioMerieux
- Sanquin
- Becton Dickinson
- Quest Diagnostics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Therapeutic Drug Monitoring by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Blood Test
- 2.2.3 Urine Test
- 2.2.4 Saliva Test
- 2.2.5 Other Test
- 2.3 Therapeutic Drug Monitoring by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital Labs
- 2.3.3 Private Labs
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Therapeutic Drug Monitoring Breakdown Data by Type
- 3.1 Global Therapeutic Drug Monitoring Historic Market Size by Type (2021-2026)
- 3.2 Global Therapeutic Drug Monitoring Forecasted Market Size by Type (2027-2032)
4 Therapeutic Drug Monitoring Breakdown Data by Application
- 4.1 Global Therapeutic Drug Monitoring Historic Market Size by Application (2021-2026)
- 4.2 Global Therapeutic Drug Monitoring Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Therapeutic Drug Monitoring Market Perspective (2021-2032)
- 5.2 Global Therapeutic Drug Monitoring Growth Trends by Region
- 5.2.1 Global Therapeutic Drug Monitoring Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Therapeutic Drug Monitoring Historic Market Size by Region (2021-2026)
- 5.2.3 Therapeutic Drug Monitoring Forecasted Market Size by Region (2027-2032)
- 5.3 Therapeutic Drug Monitoring Market Dynamics
- 5.3.1 Therapeutic Drug Monitoring Industry Trends
- 5.3.2 Therapeutic Drug Monitoring Market Drivers
- 5.3.3 Therapeutic Drug Monitoring Market Challenges
- 5.3.4 Therapeutic Drug Monitoring Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Therapeutic Drug Monitoring Players by Revenue
- 6.1.1 Global Top Therapeutic Drug Monitoring Players by Revenue (2021-2026)
- 6.1.2 Global Therapeutic Drug Monitoring Revenue Market Share by Players (2021-2026)
- 6.2 Global Therapeutic Drug Monitoring Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Therapeutic Drug Monitoring Head Office and Area Served
- 6.4 Global Therapeutic Drug Monitoring Players, Product Type & Application
- 6.5 Global Therapeutic Drug Monitoring Manufacturers Established Date
- 6.6 Global Therapeutic Drug Monitoring Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Therapeutic Drug Monitoring Market Size (2021-2032)
- 7.2 North America Therapeutic Drug Monitoring Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Therapeutic Drug Monitoring Market Size by Country (2021-2026)
- 7.4 North America Therapeutic Drug Monitoring Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Therapeutic Drug Monitoring Market Size (2021-2032)
- 8.2 Europe Therapeutic Drug Monitoring Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Therapeutic Drug Monitoring Market Size by Country (2021-2026)
- 8.4 Europe Therapeutic Drug Monitoring Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Therapeutic Drug Monitoring Market Size (2021-2032)
- 9.2 Asia-Pacific Therapeutic Drug Monitoring Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Therapeutic Drug Monitoring Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Therapeutic Drug Monitoring Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Therapeutic Drug Monitoring Market Size (2021-2032)
- 10.2 South America Therapeutic Drug Monitoring Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Therapeutic Drug Monitoring Market Size by Country (2021-2026)
- 10.4 South America Therapeutic Drug Monitoring Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Therapeutic Drug Monitoring Market Size (2021-2032)
- 11.2 Middle East & Africa Therapeutic Drug Monitoring Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Therapeutic Drug Monitoring Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Therapeutic Drug Monitoring Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Roche
- 12.1.1 Roche Company Information
- 12.1.2 Roche Business Overview
- 12.1.3 Roche Revenue in Therapeutic Drug Monitoring Business (2021-2026)
- 12.1.4 Roche Therapeutic Drug Monitoring Product Portfolio
- 12.1.5 Roche Recent Developments
- 12.2 Danaher
- 12.2.1 Danaher Company Information
- 12.2.2 Danaher Business Overview
- 12.2.3 Danaher Revenue in Therapeutic Drug Monitoring Business (2021-2026)
- 12.2.4 Danaher Therapeutic Drug Monitoring Product Portfolio
- 12.2.5 Danaher Recent Developments
- 12.3 Abbott
- 12.3.1 Abbott Company Information
- 12.3.2 Abbott Business Overview
- 12.3.3 Abbott Revenue in Therapeutic Drug Monitoring Business (2021-2026)
- 12.3.4 Abbott Therapeutic Drug Monitoring Product Portfolio
- 12.3.5 Abbott Recent Developments
- 12.4 Thermo Fisher Scientific
- 12.4.1 Thermo Fisher Scientific Company Information
- 12.4.2 Thermo Fisher Scientific Business Overview
- 12.4.3 Thermo Fisher Scientific Revenue in Therapeutic Drug Monitoring Business (2021-2026)
- 12.4.4 Thermo Fisher Scientific Therapeutic Drug Monitoring Product Portfolio
- 12.4.5 Thermo Fisher Scientific Recent Developments
- 12.5 Siemens Healthcare
- 12.5.1 Siemens Healthcare Company Information
- 12.5.2 Siemens Healthcare Business Overview
- 12.5.3 Siemens Healthcare Revenue in Therapeutic Drug Monitoring Business (2021-2026)
- 12.5.4 Siemens Healthcare Therapeutic Drug Monitoring Product Portfolio
- 12.5.5 Siemens Healthcare Recent Developments
- 12.6 Bio-Rad Laboratories
- 12.6.1 Bio-Rad Laboratories Company Information
- 12.6.2 Bio-Rad Laboratories Business Overview
- 12.6.3 Bio-Rad Laboratories Revenue in Therapeutic Drug Monitoring Business (2021-2026)
- 12.6.4 Bio-Rad Laboratories Therapeutic Drug Monitoring Product Portfolio
- 12.6.5 Bio-Rad Laboratories Recent Developments
- 12.7 BioMerieux
- 12.7.1 BioMerieux Company Information
- 12.7.2 BioMerieux Business Overview
- 12.7.3 BioMerieux Revenue in Therapeutic Drug Monitoring Business (2021-2026)
- 12.7.4 BioMerieux Therapeutic Drug Monitoring Product Portfolio
- 12.7.5 BioMerieux Recent Developments
- 12.8 Sanquin
- 12.8.1 Sanquin Company Information
- 12.8.2 Sanquin Business Overview
- 12.8.3 Sanquin Revenue in Therapeutic Drug Monitoring Business (2021-2026)
- 12.8.4 Sanquin Therapeutic Drug Monitoring Product Portfolio
- 12.8.5 Sanquin Recent Developments
- 12.9 Becton Dickinson
- 12.9.1 Becton Dickinson Company Information
- 12.9.2 Becton Dickinson Business Overview
- 12.9.3 Becton Dickinson Revenue in Therapeutic Drug Monitoring Business (2021-2026)
- 12.9.4 Becton Dickinson Therapeutic Drug Monitoring Product Portfolio
- 12.9.5 Becton Dickinson Recent Developments
- 12.10 Quest Diagnostics
- 12.10.1 Quest Diagnostics Company Information
- 12.10.2 Quest Diagnostics Business Overview
- 12.10.3 Quest Diagnostics Revenue in Therapeutic Drug Monitoring Business (2021-2026)
- 12.10.4 Quest Diagnostics Therapeutic Drug Monitoring Product Portfolio
- 12.10.5 Quest Diagnostics Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst